microRNA-1-3p and T-synthase mRNA have high diagnostic efficacy on intestinal mucosal barrier dysfunction in patients

Wen-Bo Wu1, Xiao-Fei Jiang1, Ming-Quan Chen1

  • 1Department of Emergency Medicine, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

Insights

This study found that elevated miR-1-3p and decreased T-synthase mRNA can help diagnose intestinal mucosal barrier dysfunction in severe acute pancreatitis (SAP&IBD) patients. These biomarkers are independent risk factors for SAP&IBD.

Area of Science:

  • Gastroenterology and Molecular Biology
  • Biomarker Discovery
  • Pancreatic Diseases

Background:

  • Severe acute pancreatitis (SAP) can lead to intestinal mucosal barrier dysfunction (SAP&IBD), a serious complication.
  • Effective diagnostic markers for SAP&IBD are crucial for timely intervention and improved patient outcomes.

Purpose of the Study:

  • To evaluate the diagnostic efficacy of serum miR-1-3p and T-synthase mRNA in peripheral blood B lymphocytes for identifying SAP&IBD.
  • To investigate the correlation between these biomarkers and clinical indicators of inflammation and intestinal damage.

Main Methods:

  • Serum miR-1-3p and T-synthase mRNA expression were measured in SAP patients with and without intestinal barrier dysfunction using RT-qPCR.
  • Statistical analyses included Pearson correlation, ROC curve analysis, and multivariate logistic regression.

Main Results:

  • SAP&IBD patients exhibited significantly higher serum miR-1-3p levels and lower T-synthase mRNA expression compared to SAP patients.
  • Serum miR-1-3p showed a negative correlation with T-synthase mRNA and positive correlations with Ranson score, CRP, IL-6, DAO, and D-Lactate.
  • T-synthase mRNA levels were negatively correlated with IL-6, DAO, and D-Lactate.
  • Both miR-1-3p and T-synthase mRNA, individually and in combination, demonstrated diagnostic efficiency for SAP&IBD.

Conclusions:

  • Serum miR-1-3p and T-synthase mRNA are valuable diagnostic biomarkers for intestinal mucosal barrier dysfunction in severe acute pancreatitis.
  • These biomarkers serve as independent risk factors and can aid in the diagnosis of IBD in SAP patients.

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...